Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis

https://www.sciencedirect.com/science/article/pii/S0014299915304088 Comment; Disruption of the BBB is a major problem with the toxic encephalopathy common in biotoxin illnesses, Lyme and other vector-borne illnesses. Tanshinone IIA appears to be a good resource to...